These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33614513)

  • 1. Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019.
    Shu L; Liu Y; Li J; Wu X; Li Y; Huang H
    Front Oncol; 2021; 11():624899. PubMed ID: 33614513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Profiling Analysis of CD209 in Malignancies Reveals the Therapeutic Implication for Tumor Patients Infected With SARS-CoV-2.
    Li J; Chen S; Li Y; Zhu Z; Huang H; Wang W; Yang Y; Liang Y; Shu L
    Front Genet; 2022; 13():883234. PubMed ID: 35783255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
    Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD
    J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
    Valencia I; Peiró C; Lorenzo Ó; Sánchez-Ferrer CF; Eckel J; Romacho T
    Front Pharmacol; 2020; 11():1161. PubMed ID: 32848769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury and COVID-19.
    Al-Kuraishy HM; Al-Gareeb AI
    Egypt J Intern Med; 2021; 33(1):34. PubMed ID: 34629845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors.
    Latini A; Vancheri C; Amati F; Morini E; Grelli S; Matteucci C; Petrone V; Colona VL; Murdocca M; Andreoni M; Malagnino V; Raponi M; Cocciadiferro D; Novelli A; Borgiani P; Novelli G
    J Cell Mol Med; 2022 Oct; 26(19):4940-4948. PubMed ID: 36073344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19.
    Solerte SB; Di Sabatino A; Galli M; Fiorina P
    Acta Diabetol; 2020 Jul; 57(7):779-783. PubMed ID: 32506195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2.
    Chen S; Zhang L; Song Y; Xie K; Wang Y; Liang Y
    Biochem Genet; 2024 Aug; 62(4):2399-2417. PubMed ID: 37938510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
    Filardi T; Morano S
    J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19?
    Strollo R; Pozzilli P
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3330. PubMed ID: 32336007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019.
    Wang W; Lv S; Gan W; Zeng Z; Yang M
    Ann Transl Med; 2020 Nov; 8(21):1403. PubMed ID: 33313148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
    Subbarayan K; Ulagappan K; Wickenhauser C; Bachmann M; Seliger B
    Front Immunol; 2021; 12():597399. PubMed ID: 33796097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design.
    Maleksabet H; Rezaee E; Tabatabai SA
    Curr Pharm Des; 2022; 28(45):3583-3591. PubMed ID: 36420875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.
    Posadas-Sánchez R; Sánchez-Muñoz F; Guzmán-Martín CA; Hernández-Díaz Couder A; Rojas-Velasco G; Fragoso JM; Vargas-Alarcón G
    Life Sci; 2021 Jul; 276():119410. PubMed ID: 33774023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs].
    Cao Z; Wang LT; Liu ZM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):150-158. PubMed ID: 33550350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors.
    Rahim K; Shan M; Ul Haq I; Nawaz MN; Maryam S; Alturki MS; Al Khzem AH; Metwally K; Cavalu S; Alqifari SF; Yahya G
    J Inflamm Res; 2024; 17():1897-1917. PubMed ID: 38544813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections.
    Mani S; Kaur A; Jakhar K; Kumari G; Sonar S; Kumar A; Das S; Kumar S; Kumar V; Kundu R; Pandey AK; Singh UP; Majumdar T
    Int J Biol Macromol; 2023 Aug; 245():125444. PubMed ID: 37385308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses.
    Lim HT; Kok BH; Lim CP; Abdul Majeed AB; Leow CY; Leow CH
    Biomed Eng Adv; 2022 Dec; 4():100054. PubMed ID: 36158162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the SARS-CoV-2 Spike Protein Receptor Binding Domain Interact Effectively with the DPP4 (CD26) Receptor? A Molecular Docking Study.
    Cameron K; Rozano L; Falasca M; Mancera RL
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.